R Lalonde

677 total citations
20 papers, 440 citations indexed

About

R Lalonde is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, R Lalonde has authored 20 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in R Lalonde's work include HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). R Lalonde is often cited by papers focused on HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers) and HIV/AIDS Research and Interventions (5 papers). R Lalonde collaborates with scholars based in Canada and United Kingdom. R Lalonde's co-authors include Bruce E. Holbein, Vivian G. Loo, Evan G. Wong, Lisa Koski, Ami Tsuchida, Lesley K. Fellows, William Hodge, John S. Sampalis, Emil Toma and Hugh G. Robson and has published in prestigious journals such as Journal of Clinical Investigation, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

R Lalonde

19 papers receiving 418 citations

Peers

R Lalonde
F. Ajana France
Amrei von Braun Germany
Peter Mariuz United States
Albert Dompreh Ghana
Henrique Lecour Portugal
Joseph A. McBride United States
P. Samuel Pegram United States
Eliahou Bishburg United States
Valérie Garrait France
Jean A. Smith United States
F. Ajana France
R Lalonde
Citations per year, relative to R Lalonde R Lalonde (= 1×) peers F. Ajana

Countries citing papers authored by R Lalonde

Since Specialization
Citations

This map shows the geographic impact of R Lalonde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Lalonde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Lalonde more than expected).

Fields of papers citing papers by R Lalonde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Lalonde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Lalonde. The network helps show where R Lalonde may publish in the future.

Co-authorship network of co-authors of R Lalonde

This figure shows the co-authorship network connecting the top 25 collaborators of R Lalonde. A scholar is included among the top collaborators of R Lalonde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Lalonde. R Lalonde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Koski, Lisa, et al.. (2011). Computerized testing augments pencil-and-paper tasks in measuring HIV-associated mild cognitive impairment*. HIV Medicine. 12(8). 472–480. 66 indexed citations
3.
Tremblay, Cécile, Benoît Trottier, Anita Rachlis, et al.. (2011). Treatment Durability, Effectiveness, and Safety with Atazanavir/Ritonavir-Based HAART Regimen in Treatment-Naïve HIV-lnfected Patients. HIV Clinical Trials. 12(3). 151–160. 2 indexed citations
4.
Lalonde, R, Réjean Thomas, Anita Rachlis, et al.. (2009). Successful implementation of a national HLA‐B*5701 genetic testing service in Canada. Tissue Antigens. 75(1). 12–18. 21 indexed citations
5.
6.
Machouf, Nimâ & R Lalonde. (2006). La thérapie sous observation directe (DOT): de la tuberculose au VIH. Revue d Épidémiologie et de Santé Publique. 54(1). 73–89. 4 indexed citations
7.
Shafran, Stephen, Barbara R. Conway, Jean Vincelette, et al.. (2002). Field Evaluation of the Merlin Immediate HIV-1 and -2 Test for Point-of-Care Detection of Human Immunodeficiency Virus Antibodies. Clinical Infectious Diseases. 34(5). 658–661. 4 indexed citations
8.
Lalonde, R, et al.. (2000). HIV/AIDS telephone consultation service to support the practice of health professionals in Quebec. Journal of Telemedicine and Telecare. 6(1_suppl). 201–201. 2 indexed citations
9.
10.
Klein, Marina B. & R Lalonde. (1997). The Continued Occurrence of Primary Pneumocystis carinii Pneumonia Despite the Availability of Prophylaxis. Clinical Infectious Diseases. 24(3). 522–523. 5 indexed citations
11.
12.
Hodge, William, R Lalonde, John S. Sampalis, & Jean Deschênes. (1996). Once-Weekly Intraocular Injections of Ganciclovir for Maintenance Therapy of Cytomegalovirus Retinitis: Clinical and Ocular Outcome. The Journal of Infectious Diseases. 174(2). 393–396. 31 indexed citations
13.
Lalonde, R, et al.. (1994). Inhibitory effect of 3'-azido-3'-deoxythymidine on proliferative responsiveness of CD8+ lymphocytes to interleukin-2. Clinical and Diagnostic Laboratory Immunology. 1(4). 482–485. 3 indexed citations
14.
Lalonde, R, Pierre René, & Mark A. Wainberg. (1993). Opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: report of two cases.. PubMed. 149(2). 179–82. 4 indexed citations
15.
Lalonde, R, et al.. (1990). Long-standing Symptomatic Cryptosporidiosis in a Normal Man. Journal of Clinical Gastroenterology. 12(2). 190–191. 11 indexed citations
16.
Robson, Hugh G., et al.. (1990). Tuberculous pancreatitis. Tubercle. 71(1). 65–68. 31 indexed citations
17.
Nguyen, Christopher & R Lalonde. (1990). Risk of occupational exposure to Herpesvirus simiae (B virus) in Quebec.. PubMed. 143(11). 1203–6. 3 indexed citations
18.
Mandell, Lionel A., Michel G. Bergeron, Allan Ronald, et al.. (1989). Once-Daily Therapy with Ceftriaxone Compared with Daily Multiple-Dose Therapy with Cefotaxime for Serious Bacterial Infections: A Randomized, Double-Blind Study. The Journal of Infectious Diseases. 160(3). 433–441. 36 indexed citations
19.
Lalonde, R & Bruce E. Holbein. (1984). Role of iron in Trypanosoma cruzi infection of mice.. Journal of Clinical Investigation. 73(2). 470–476. 65 indexed citations
20.
Loo, Vivian G. & R Lalonde. (1984). Role of iron in intracellular growth of Trypanosoma cruzi. Infection and Immunity. 45(3). 726–730. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Ajana Breakdown of academic impact, for papers by Amrei von Braun Breakdown of academic impact, for papers by Peter Mariuz Breakdown of academic impact, for papers by Albert Dompreh Breakdown of academic impact, for papers by Henrique Lecour Breakdown of academic impact, for papers by Joseph A. McBride Breakdown of academic impact, for papers by P. Samuel Pegram Breakdown of academic impact, for papers by Eliahou Bishburg Breakdown of academic impact, for papers by Valérie Garrait Breakdown of academic impact, for papers by Jean A. Smith
Rankless by CCL
2026